Aligos therapeutics to announce 1st quarter 2024 financial results on may 7, 2024

South san francisco, calif., april 30, 2024 (globe newswire) -- aligos therapeutics, inc. (nasdaq: algs, “aligos”), a clinical stage biopharmaceutical company focused on developing novel therapeutics to address unmet medical needs in liver and viral diseases, today announced that it will report the company's first quarter 2024 financial results on tuesday, may 7, 2024, after the close of the u.s. financial markets.
ALGS Ratings Summary
ALGS Quant Ranking